MPTP-Induced Dopamine Depletion in Basolateral Amygdala Decrease of D2R Activation Suppresses GABA Receptors Expression and LTD Induction Leading to Anxiety-Like Behaviors
Overview
Affiliations
Anxiety disorders commonly occur in Parkinson's disease. Using field potential recording and patch-clamp recording, we evaluated influence of MPTP-reduced dopaminergic afferent in basolateral amygdala (BLA), a main region for affective regulation, on excitatory-inhibitory circuits and synaptic plasticity. Field excitatory post-synaptic potential (fEPSP) slopes at external capsule-BLA synapses were increased in MPTP-mice with decreases in paired-pulse facilitation and long-term potentiation amplitude, which were corrected by bath-application of D2R agonist quinpirole or cannabinoid type 1 receptors agonist WIN55,212-2, but not D1R agonist SKF38393. Compared to single waveform fEPSP in control mice, a multi-spike waveform fEPSP was observed in MPTP-mice with prolongation of duration and an increase in paired-pulse inhibition, which were recovered by BLA-injection of quinpirole for 2 days rather than bath-application. Density of GABA-evoked current () in BLA principal neurons and GABAR-α2 subunit expression were reduced in MPTP-mice, which were recovered by administration of quinpirole. Decline of PKC phosphorylation in BLA of MPTP-mice was corrected by bath-application of quinpirole, but not SKF38393. In MPTP-mice, BLA-injection of quinpirole or PKC activator PMA could recover GABAR expression, which was sensitive to PKC inhibitor GF109203X. The impairment of long-term depression (LTD) in MPTP-mice was rescued by bath-application of GABAR agonist muscimol or BLA-injection of quinpirole and PMA. Finally, BLA-injection of muscimol, quinpirole or PMA relieved anxiety-like behaviors in MPTP-mice. The results indicate that the MPTP-induced dopamine depletion in BLA principal neurons through reducing D2R-mediated PKC phosphorylation suppresses GABAR expression and activity, which impairs GABAR-mediated inhibition and LTD induction leading to anxiety-like behaviors.
Sohi K, Sueun L, Byeong Cheol M, Jun Ho S, Sung-Ho K, Changjong M J Tradit Chin Med. 2024; 44(6):1111-1117.
PMID: 39617696 PMC: 11589551. DOI: 10.19852/j.cnki.jtcm.2024.06.002.
Thi Lai T, Gericke B, Feja M, Conoscenti M, Zelikowsky M, Richter F NPJ Parkinsons Dis. 2023; 9(1):97.
PMID: 37349373 PMC: 10287685. DOI: 10.1038/s41531-023-00547-4.
Amygdalo-nigral circuit mediates stress-induced vulnerability to the parkinsonian toxin MPTP.
Cai H, Zhang P, Li T, Li M, Zhang L, Cui C CNS Neurosci Ther. 2023; 29(7):1940-1952.
PMID: 36914579 PMC: 10324352. DOI: 10.1111/cns.14151.
Qin Y, Xu W, Li K, Luo Q, Chen X, Wang Y Front Mol Neurosci. 2022; 15:959224.
PMID: 36245919 PMC: 9563353. DOI: 10.3389/fnmol.2022.959224.
αCaMKII in the lateral amygdala mediates PTSD-Like behaviors and NMDAR-Dependent LTD.
An S, Wang J, Zhang X, Duan Y, Xu Y, Lv J Neurobiol Stress. 2021; 15:100359.
PMID: 34258335 PMC: 8252123. DOI: 10.1016/j.ynstr.2021.100359.